Literature DB >> 12489613

Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.

Wendy J Blumenthal1, Kristen W Springer, T Stephen Jones, Claire E Sterk.   

Abstract

OBJECTIVE: To explore pharmacy school education and pharmacy students' knowledge, attitudes, and beliefs about human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS), drug use, and syringe sales to injection drug users (IDUs).
DESIGN: Qualitative study of a convenience sample of pharmacy school students.
SETTING: A pharmacy school in the southeastern United States. INTERVENTION: Two focus groups and nine in-depth interviews were conducted about HIV/AIDS education and counseling, syringe sales to possible IDUs, and related pharmacy school education. PARTICIPANTS: 19 Doctor of Pharmacy students, including 88 students in their third professional year and 11 in their fourth professional year.
RESULTS: Most participants believed that they would benefit from more class time on HIV/AIDS topics, including AIDS treatment medications and HIV prevention. Most participants believed that the laws and regulations governing syringe sales in their state were vague, leaving syringe sale decisions to pharmacists' discretion. Nine study participants supported selling syringes to possible IDUs, five opposed it, and five were undecided or ambivalent. Classroom education focused on addiction to prescription drugs, with limited attention to illicit drug use.
CONCLUSION: Pharmacy students have divided opinions about selling syringes to IDUs. To prepare students for helping their patients with drug-use problems, pharmacy schools should increase training about HIV/AIDS and addiction. Policy makers should consider changing laws and regulations of syringe sales to recognize prevention of blood-borne infections as a legitimate medical purpose for selling syringes to IDUs.

Entities:  

Mesh:

Year:  2002        PMID: 12489613     DOI: 10.1331/1086-5802.42.0.s34.blumenthal

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  8 in total

1.  Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings.

Authors:  Alexandra Lutnick; Patricia Case; Alex H Kral
Journal:  J Urban Health       Date:  2012-04       Impact factor: 3.671

2.  Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.

Authors:  Alexandra Lutnick; Erin Cooper; Chaka Dodson; Ricky Bluthenthal; Alex H Kral
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

3.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

4.  Adverse event associated with a change in nonprescription syringe sale policy.

Authors:  Nickolas D Zaller; Michael A Yokell; Alexandra Jeronimo; Jeffrey P Bratberg; Patricia Case; Josiah D Rich
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Sep-Oct

5.  Nonprescription syringe sales: a missed opportunity for HIV prevention in California.

Authors:  Robin A Pollini; Abby E Rudolph; Patricia Case
Journal:  J Am Pharm Assoc (2003)       Date:  2015 Jan-Feb

6.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

7.  A multistate trial of pharmacy syringe purchase.

Authors:  Wilson M Compton; Joe C Horton; Linda B Cottler; Robert Booth; Carl G Leukefeld; Merrill Singer; Renee Cunningham-Williams; Wendy Reich; Karen Fortuin Corsi; Michele Staton; Joseph L Fink; Thomas J Stopka; Edward L Spitznagel
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

8.  Not sold here: limited access to legally available syringes at pharmacies in Tijuana, Mexico.

Authors:  Robin A Pollini; Perth C Rosen; Manuel Gallardo; Brenda Robles; Kimberly C Brouwer; Grace E Macalino; Remedios Lozada
Journal:  Harm Reduct J       Date:  2011-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.